LYCA
Lycia Therapeutics, Inc. · NASDAQ:LYCA
26.40 USD−1.33 −4.80%
Lycia Therapeutics, Inc. (NASDAQ:LYCA) last traded at 26.40 USD, down 4.80% on the day. Over the past year the stock is down 7.53%. Its 52-week range is 22.19 to 36.49. It is in the Health Technology sector (Biotechnology).
Key statistics
Open27.17
Day range25.66 – 27.59
52-week range22.19 – 36.49
Volume202.45 K
Market cap1.52 B
Dividend yield0.00%
Performance
−7.53%1 week
−7.53%1 month
−7.53%3 months
−7.53%6 months
−7.53%Year to date
−7.53%1 year
Latest headlines
- Lycia Therapeutics Announces Closing Of Upsized Initial Public OfferingReuters · 26 Oct 2026
- Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewswire · 26 Oct 2026
- Lycia Therapeutics, Inc. (LYCA) Closes Upsized IPO, Raises ~$365.1M at $18/ShareTradingView · 26 Oct 2026
- Weekly Recap: Lycia Therapeutics $317.5M IPO and Lilly ends fundingTradingView · 26 Oct 2026
- REG - RTW Biotech Opp. - Lycia Therapeutics prices $318 million IPOLondon Stock Exchange · 26 Oct 2026
- Key facts: Lycia Therapeutics advances two LYTAC degraders; HBM $13.5MTradingView · 26 Oct 2026
- HBM Portfolio Company Lycia Therapeutics Raises USD 317.5 Million in Nasdaq IPO and Delivers Strong Market DebutEQS · 26 Oct 2026
- Forget Anthropic: Biotech Is Quietly Dominating the IPO Sphere — Barrons.comDow Jones Newswires · 24 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.